High-definition Transcranial Direct Current Stimulation (HD-tDCS) Verbal Learning

This study is currently recruiting participants.
Verified November 2012 by The University of New South Wales
Sponsor:
Information provided by:
The University of New South Wales
ClinicalTrials.gov Identifier:
NCT01733576
First received: November 26, 2012
Last updated: June 14, 2013
Last verified: November 2012
  Purpose

This project will use a new form of non-invasive brain stimulation called high-definition transcranial direct current stimulation (HD-tDCS) to facilitate verbal learning. This form of stimulation is similar to transcranial direct current stimulation (tDCS) but allows for more spatially focused stimulation. We hypothesise that HD-tDCS when applied to regions of the brain important for learning and memory will improve verbal learning and memory compared to sham HD-tDCS.


Condition Intervention Phase
Verbal Learning and Memory
Device: HD-tDCS
Phase 0

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Official Title: Enhancing Verbal Learning and Memory Using High-Definition Transcranial Direct Current Stimulation (HD-tDCS)

Resource links provided by NLM:


Further study details as provided by The University of New South Wales:

Primary Outcome Measures:
  • Ray Auditory Verbal Learning Test (RAVLT) [ Designated as safety issue: No ]

Estimated Enrollment: 16
Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Sham Comparator: Sham HD-tDCS Device: HD-tDCS
Active Comparator: Active HD-tDCS 1 Device: HD-tDCS
Active Comparator: Active HD-tDCS 2 Device: HD-tDCS
Active Comparator: Active HD-tDCS 3 Device: HD-tDCS

  Eligibility

Ages Eligible for Study:   18 Years to 40 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Ages 18 - 40 years
  • Right-handed

Exclusion Criteria:

  • concurrent medication likely to affect mental performance
  • current history of drug or alcohol abuse or dependence
  • any psychiatric or neurological disorder, recent head injury, or history of seizure or stroke.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01733576

Contacts
Contact: Donel Martin, PhD 61 2 9382 9261 donel.martin@unsw.edu.au

Locations
Australia, New South Wales
Black Dog Institute Recruiting
Sydney, New South Wales, Australia, 2031
Contact: Donel Martin, PhD    61 2 9382 9261    donel.martin@unsw.edu.au   
Principal Investigator: Donel Martin, PhD         
Sponsors and Collaborators
The University of New South Wales
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01733576     History of Changes
Other Study ID Numbers: CB64
Study First Received: November 26, 2012
Last Updated: June 14, 2013
Health Authority: Australia: Therapeutic Goods Administration

ClinicalTrials.gov processed this record on April 15, 2014